$AIM

$0.17▲ -5.6% YTD

2 SEC 13D/G filings tracked · Last updated Oct 1, 2026

Filing History

CP $0.17▲ -5.6%Oct 1, 2026 · ThinkSabio Blog

$AIM - AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data…

News

AIM ▼ -8.3% - AIM ImmunoTech Inc.

CP $0.22▲ -8.3%Sep 2, 2026 · ThinkSabio Blog

$AIM - AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 204…